(OSCV) Opus Small Cap Value Plus - Overview
Etf: Stocks, Reits, Adrs
Dividends
| Dividend Yield | 1.23% |
| Yield on Cost 5y | 1.60% |
| Yield CAGR 5y | 4.93% |
| Payout Consistency | 92.5% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 15.0% |
| Relative Tail Risk | -6.59% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.42 |
| Alpha | -2.30 |
| Character TTM | |
|---|---|
| Beta | 0.713 |
| Beta Downside | 0.736 |
| Drawdowns 3y | |
|---|---|
| Max DD | 22.92% |
| CAGR/Max DD | 0.41 |
Description: OSCV Opus Small Cap Value Plus December 26, 2025
Opus Small Cap Value Plus (BATS: OSCV) is an actively managed ETF that allocates at least 80% of its net assets-plus any investment-purpose borrowings-to equities of U.S. small-cap companies, defined as the lowest 15% of the market-cap spectrum on an annual basis. The portfolio is concentrated in common stocks, REITs, and ADRs, aiming to capture value-oriented upside in the lower-tier segment of the U.S. equity market.
As of Q3 2024, OSCV reports an expense ratio of 0.45% and total assets under management of roughly $150 million, with a 12-month total return of about 7.2% (net of fees). The fund’s top sectors are industrials (≈22%), financials (≈19%), and consumer discretionary (≈15%), reflecting the typical composition of U.S. small-cap value indices. Key macro drivers include U.S. GDP growth rates (small-cap firms tend to outperform when the economy expands) and the Federal Reserve’s policy stance, since lower-rate environments reduce financing costs for these capital-intensive companies.
For a deeper dive into OSCV’s risk-adjusted performance metrics and peer comparison, you may find the ValueRay analytics platform a useful next step.
What is the price of OSCV shares?
Over the past week, the price has changed by +5.15%, over one month by +8.56%, over three months by +12.37% and over the past year by +10.38%.
Is OSCV a buy, sell or hold?
What are the forecasts/targets for the OSCV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 44.5 | 8.3% |
OSCV Fundamental Data Overview February 02, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 670.9m USD (670.9m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 670.9m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 670.9m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.54% (E(670.9m)/V(670.9m) * Re(8.54%) + (debt-free company))
Discount Rate = 8.54% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)